Therapeutic options for neuromuscular diseases.
Kent
Marc
M
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, 501 DW Brooks Drive, Athens, GA 30602, USA. MKent@vet.uga.edu
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000628:therapy*; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D019587:Dietary Supplements; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D005938:Glucocorticoids / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009468:Neuromuscular Diseases / Q000628:therapy / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D002800:Cholinesterase Inhibitors; D005938:Glucocorticoids; D007166:Immunosuppressive Agents